Five Deans Technology Showcases E-Cigarette Products at Dortmund Tobacco Exhibition

Sep.15.2022
Five Deans Technology Showcases E-Cigarette Products at Dortmund Tobacco Exhibition
Five Deans showcased their e-cigarettes at the Dortmund Tobacco Exhibition, featuring colorful designs and large capacities.

On September 15th at 10:00 am local time (4:00 pm Beijing time), the Dortmund Tobacco Expo grandly opened at the Dortmund Exhibition Center, covering an area of over 40,000 square meters. As a well-known OEM/ODM enterprise in the industry, Wulian Technology, a subsidiary of listed company Five Rings Group, proudly showcased its full range of electronic cigarette products at booth 1.A28, including CBD products and disposable e-cigarette series.


Visitors to the tobacco exhibition in Dortmund, Germany, had the opportunity to experience five top-notch electronic cigarette products.


Nextvapor Wudian Technology focuses on trendy designs and colorful packaging, emphasizing the currently popular large capacity and wide-mouthed products. Its brand DUNKE offers disposable electronic cigarettes, pod vapes, and accessories, while the BTBE brand's ONX disposable CBD electronic cigarette has also gained popularity among exhibition attendees for its sleek design.


Wodian Technology's electronic cigarette product line.


Widely popular in the global market, Wodian Technology boasts a comprehensive line of disposable electronic cigarettes, ranging from 2ml to a massive 16ml capacity, complying with European standards. The products come in different shapes and an array of colors that attract the attention of onlookers. Additionally, their pod vape products have a capacity of up to 5ml, catering to current customers' preference for high-capacity products.


Visitors at the Dortmund Tobacco Expo in Germany had the opportunity to try out the product line of electronic cigarettes from Wodian Technology.


Wudian Technology focuses on the research and development, production, sales, and service of electronic cigarettes. The factory covers an area of over 30,000 square meters with a monthly production capacity of up to 2400K. Since its establishment in 2017, the company has grown rapidly and now owns brands such as Dunke, BTBE, and NEXTVAPOR. Its CBD business has particularly shown impressive growth and has reached the TOP3 ranking in the CBD industry in 2021.


Exhibition poster of Wu Dian.


To read more about the latest news and reports on the Dortmund tobacco exhibition in Germany, please click on the link below.


1. This article is intended solely for internal discussion and communication within the industry, and does not make any brand or product promotions or recommendations. 2. Smoking is detrimental to health. Minors are prohibited from reading this article.


This article is an original work of 2FIRSTS Technology Co., Ltd. in Shenzhen, and its copyright and permission for use belong to the company. No individual or organization is allowed to copy, reprint, or infringe upon the company's copyright without authorization. If anyone violates these terms, the company reserves the right to pursue legal action.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
European Ombudswoman Teresa Anjinho has opened an inquiry into how the European Commission’s Directorate-General for Trade handles interactions with the tobacco industry. The case follows a complaint from a civil society organisation that alleges regular, unnecessary and non-transparent contacts between DG TRADE and tobacco industry representatives, raising questions over compliance with the EU’s obligations under the WHO Framework Convention on Tobacco Control. The inquiry remains ongoing, and the Ombudswoman has not reached any finding of maladministration.
Aug.24
China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
The Zhengzhou Tobacco Research Institute of China National Tobacco Corporation has filed a patent application for an end-to-end method to analyze the migration and transformation of chemical compounds in heated tobacco products. Using GC-Orbitrap/MS non-targeted analysis, the method compares tobacco substrate and aerosol samples to distinguish compounds transferred directly from the substrate from those newly formed during heating, while also calculating transfer rates. In an example involving nine heated tobacco products, the patent identified 17 newly formed thermal decomposition compounds and 38 transferred compounds.
Aug.13
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia's federal government introduced a new illicit tobacco enforcement bill on September 10 that would strengthen evidentiary presumptions, representative sampling, seizure and forfeiture procedures, proceeds-of-crime powers and obligations for customs and logistics operators. The proposal follows the Combatting Illicit Tobacco Act 2026, which took effect in August and increased penalties while expanding investigative and asset-recovery tools. Together, the reforms extend Australia's crackdown from tougher criminal sanctions into import, logistics and evidentiary enforcement.
Sep.14
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04